APA (7th ed.) Citation

MR, B., R, B., PAH, D., MPW, I., JJW, L., ALHMW, v. L., . . . S, M. (2022). Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation. Clinical and translational radiation oncology, 34, 82. https://doi.org/10.1016/j.ctro.2022.03.008

Chicago Style (17th ed.) Citation

MR, Boekhoff, et al. "Clinical Implementation and Feasibility of Long-course Fractionated MR-guided Chemoradiotherapy for Patients with Esophageal Cancer: An R-IDEAL Stage 1b/2a Evaluation of Technical Innovation." Clinical and Translational Radiation Oncology 34 (2022): 82. https://doi.org/10.1016/j.ctro.2022.03.008.

MLA (9th ed.) Citation

MR, Boekhoff, et al. "Clinical Implementation and Feasibility of Long-course Fractionated MR-guided Chemoradiotherapy for Patients with Esophageal Cancer: An R-IDEAL Stage 1b/2a Evaluation of Technical Innovation." Clinical and Translational Radiation Oncology, vol. 34, 2022, p. 82, https://doi.org/10.1016/j.ctro.2022.03.008.